Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post Myocardial Infarction

Study Questions:

What are the outcomes of post-infarction patients who receive a wearable cardioverter-defibrillator (WCD) while waiting the mandated 40 days (or 3 months if revascularization has been performed) for an implantable cardioverter-defibrillator (ICD)?

Not a Member?

As a member of the ACC, you'll get full access to all articles, clinical research, and more!